PHVS

Conviction 89HealthcareScan · Mon, Aug 10, 2026

PHVS$34.82-0.26%

ResistanceSupportVol 14Insider sell

Vol MA14 383.53K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Pharvaris N.V.Biotechnologywww.pharvaris.com ↗

Price34.82

Change-0.26%

Gap+0.60%

Rel volume1.46×

Avg volume347.31K

Avg $ vol11.79M

SMA 2033.92

SMA 5033.20

SMA 20028.31

Price vs 50+4.87%

Price vs 200+22.98%

MA stackbullish

50/200 cross—

Supertrendup · 31.20

RSI (14)56

MACD hist0.06

MACD crossbull · 1d

Stoch %K / %D73 / 71

ADX (14)19

+DI / −DI21 / 15

RSI divergence—

MACD divergence—

ATR %+4.58%

ADR %4.46%

52w high35.96

52w low20.12

From 52w high-3.17%

Above 52w low+73.06%

New 52w highNo

SqueezeOn · 4d

Bollinger width9.35%

%B0.78

Donchian pos73.39%

Donchian high36.02

Donchian low31.51

AVWAP (52w high)34.49

vs AVWAP high+0.94%

AVWAP (52w low)28.55

vs AVWAP low+21.97%

OBV trendFlat

Chaikin MF (20)-0.11

Today vs 20d1.46×

Avg vol (14d)383.53K

Avg vol (20d)347.31K

Avg $ vol (20d)11.79M

Market cap—

RS 3m (vs SPY)+11.92%

RS 6m (vs SPY)+24.75%

RS line new highNo

Trend template8/8

Technical rank75.1

1 week+7.97%

1 month-0.71%

3 months+15.72%

6 months+31.79%

1 year+71.36%

YTD+31.50%

P/E—

P/B—

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current—

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target51.10

Target upside46.54%

Analyst ratingBuy

Institutional85.44%

Ent. value2.27B

Revenue—

Net income—

Gross profit—

Free cash flow—

IndustryBiotechnology

ExchangeNasdaq

Shares out—

Employees129

ListedFri, Feb 5, 2021

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA+

Conviction89 / 100

Pattern quality—

Tech rank75.1 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance36.31

Support31.78

Days since event—

Candle confirm—

News sentiment—

Congress activity

Disclosed STOCK Act trades in PHVS

All disclosures →

No recent disclosed trades by Congress in PHVS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in PHVS · 2 buys · 8 sells

Insider	Side	Shares	Value	Traded	Filed
Modig Berndt Chief Executive Officer · Common Stock · 2026-07-13	Sell	2.29K	$80K	2026-07-13	2026-07-15
Schikan Johannes Gerardus Christiaan Petrus Director · Common Stock · 2026-06-29	Sell	2.4K	$84K	2026-06-29	2026-06-29
Lu Peng Chief Medical Officer · Common Stock · 2026-06-26	Sell	14.7K	$500K	2026-06-26	2026-06-29
Lu Peng Chief Medical Officer · Common Stock · 2026-06-26	Exercise	14.7K	$38K	2026-06-26	2026-06-29
Lu Peng Chief Medical Officer · Stock Option (Right to Buy) · 2026-06-26	Exercise	14.7K	—	2026-06-26	2026-06-29
Lesage Anne Chief Early Development · Common Stock · 2026-06-25	Sell	2.3K	$81K	2026-06-25	2026-06-29
Lesage Anne Chief Early Development · Common Stock · 2026-06-25	Sell	2.3K	$81K	2026-06-25	2026-06-29
Lesage Anne Chief Early Development · Stock Option (Right to Buy) · 2026-06-25	Exercise	900	—	2026-06-25	2026-06-29
Lesage Anne Chief Early Development · Stock Option (Right to Buy) · 2026-06-25	Exercise	1.4K	—	2026-06-25	2026-06-29
Lu Peng Chief Medical Officer · Common Stock · 2026-06-25	Exercise	15K	$39K	2026-06-25	2026-06-29

SEC filings

EDGAR filings in PHVS · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.